Stay updated on Durvalumab and Daratumumab in MM Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Daratumumab in MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Daratumumab in MM Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and MedlinePlus Genetics.
    Difference
    0.1%
    Check dated 2026-04-11T10:39:59.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Padua, Italy, 35128 has been updated to Padova, Italy, 35128. The page also shows removals of "Multiple myeloma", the related topic "MedlinePlus Genetics", and the old Padua location.
    Difference
    0.2%
    Check dated 2026-04-04T06:11:26.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    - Added 'Multiple myeloma' as a topic and linked 'MedlinePlus Genetics' as a related topic to improve content context and navigation. - Updated page revision to v3.5.0, replacing the older v3.4.3 revision.
    Difference
    0.1%
    Check dated 2026-03-21T01:04:24.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Removed mentions of 'Multiple Myeloma' and related topics from the page, reducing coverage of the study's focus and reference materials.
    Difference
    0.1%
    Check dated 2026-03-13T19:46:00.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and MedlinePlus Genetics; updated revision to v3.4.3 and removed v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-06T18:02:04.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page revision updates metadata to v3.4.2 and removes non-core topic entries (Multiple Myeloma, MedlinePlus Genetics). No core study content, such as trial design, eligibility criteria, interventions, or primary outcomes, was changed; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:34:00.000Z thumbnail image

Stay in the know with updates to Durvalumab and Daratumumab in MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Daratumumab in MM Clinical Trial page.